title: Exercise and thrombosis.
abstract: Long-term moderate or strenuous physical activity is associated with a considerable reduction in cardiovascular morbidity and mortality in primary and secondary prevention. Various mechanisms, including changes in lipids, lifestyle habits, and other positive physiologic effects, have been suggested to mediate these beneficial effects. In addition, the hemostatic and fibrinolytic systems appear to play an important role. Fibrinogen has been convincingly shown to be an independent cardiovascular risk factor. Other hemostatic and fibrinolytic parameters that are predictive of coronary events include factor VII, platelet hyperreactivity, plasminogen-activator inhibitor 1 (PAI-1), and tissue-plasminogen activator. The effects of exercise on fibrinogen have been intensively studied. Several randomized controlled trials, various other intervention studies and a large number of population-based cross-sectional studies all found an inverse relationship between measures of sport activity or leisure activity and plasma fibrinogen. The magnitude of the effect reported might be associated with a sizeable reduction in major coronary events. Relatively few data are available on the effects of endurance exercise on markers of the fibrinolytic system, with inconsistent results. Acute exercise leads to a transient activation of the coagulation system, which is accompanied by an increase in the fibrinolytic capacity in healthy subjects. Patients with ischemic heart disease, who cannot increase their fibrinolytic potential, however, may be at considerable risk for acute ischemic events if they are exposed to unaccustomed strenuous physical exertion.
authors.affiliation: Department of Internal Medicine II-Cardiology, University of Ulm Medical Centre, Ulm, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Imhof
authors.forename: W
authors.initials: W
authors.lastname: Koenig
mesh_terms: D001779:Blood Coagulation Factors / Q000378:metabolism; D003328:Coronary Thrombosis / Q000097:blood* / Q000401:mortality / Q000517:prevention & control; D003430:Cross-Sectional Studies; D015444:Exercise / Q000502:physiology*; D005342:Fibrinolysis / Q000502:physiology*; D006487:Hemostasis / Q000502:physiology*; D006801:Humans; D010807:Physical Endurance / Q000502:physiology; D015996:Survival Rate
chemical_list: D001779:Blood Coagulation Factors